These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 27702698)

  • 1. Life and death in the trash heap: The ubiquitin proteasome pathway and UCHL1 in brain aging, neurodegenerative disease and cerebral Ischemia.
    Graham SH; Liu H
    Ageing Res Rev; 2017 Mar; 34():30-38. PubMed ID: 27702698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of UCHL1 in the pathogenesis of neurodegenerative diseases and brain injury.
    Mi Z; Graham SH
    Ageing Res Rev; 2023 Apr; 86():101856. PubMed ID: 36681249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abolishing UCHL1's hydrolase activity exacerbates TBI-induced axonal injury and neuronal death in mice.
    Mi Z; Liu H; Rose ME; Ma X; Reay DP; Ma J; Henchir J; Dixon CE; Graham SH
    Exp Neurol; 2021 Feb; 336():113524. PubMed ID: 33159930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Could dysregulation of UPS be a common underlying mechanism for cancer and neurodegeneration? Lessons from UCHL1.
    Jara JH; Frank DD; Özdinler PH
    Cell Biochem Biophys; 2013 Sep; 67(1):45-53. PubMed ID: 23695785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Podocyte-specific deletion of ubiquitin carboxyl-terminal hydrolase L1 causes podocyte injury by inducing endoplasmic reticulum stress.
    Hu Y; Qi C; Shi J; Tan W; Adiljan Abdurusul ; Zhao Z; Xu Y; Wu H; Zhang Z
    Cell Mol Life Sci; 2023 Mar; 80(4):106. PubMed ID: 36952018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aging and regulated protein degradation: who has the UPPer hand?
    Vernace VA; Schmidt-Glenewinkel T; Figueiredo-Pereira ME
    Aging Cell; 2007 Oct; 6(5):599-606. PubMed ID: 17681036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Regulation of the protein degradation pathway by the ubiquitin family: its implication in neurodegenerative diseases].
    Chiba T; Tanaka K
    Rinsho Shinkeigaku; 2005 Nov; 45(11):976-8. PubMed ID: 16447778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of UCHL1 in axonal injury and functional recovery after cerebral ischemia.
    Liu H; Povysheva N; Rose ME; Mi Z; Banton JS; Li W; Chen F; Reay DP; Barrionuevo G; Zhang F; Graham SH
    Proc Natl Acad Sci U S A; 2019 Mar; 116(10):4643-4650. PubMed ID: 30760601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of BACE1 degradation and APP processing by ubiquitin carboxyl-terminal hydrolase L1.
    Zhang M; Deng Y; Luo Y; Zhang S; Zou H; Cai F; Wada K; Song W
    J Neurochem; 2012 Mar; 120(6):1129-38. PubMed ID: 22212137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of ubiquitin-proteasome-mediated proteolysis in nervous system disease.
    Hegde AN; Upadhya SC
    Biochim Biophys Acta; 2011 Feb; 1809(2):128-40. PubMed ID: 20674814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the ubiquitin-proteasomal pathway in Parkinson's disease and other neurodegenerative disorders.
    Chung KK; Dawson VL; Dawson TM
    Trends Neurosci; 2001 Nov; 24(11 Suppl):S7-14. PubMed ID: 11881748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitin, proteasomes, and the aging brain.
    Gray DA; Tsirigotis M; Woulfe J
    Sci Aging Knowledge Environ; 2003 Aug; 2003(34):RE6. PubMed ID: 12944592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation of a Ubiquitin Carboxy Terminal Hydrolase L1 Lipid Binding Site Alleviates Cell Death, Axonal Injury, and Behavioral Deficits After Traumatic Brain Injury in Mice.
    Mi Z; Liu H; Rose ME; Ma J; Reay DP; Ma X; Henchir JJ; Dixon CE; Graham SH
    Neuroscience; 2021 Nov; 475():127-136. PubMed ID: 34508847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ubiquitin C-Terminal Hydrolase L1 is required for regulated protein degradation through the ubiquitin proteasome system in kidney.
    Radón V; Czesla M; Reichelt J; Fehlert J; Hammel A; Rosendahl A; Knop JH; Wiech T; Wenzel UO; Sachs M; Reinicke AT; Stahl RAK; Meyer-Schwesinger C
    Kidney Int; 2018 Jan; 93(1):110-127. PubMed ID: 28754552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the ubiquitin-proteasome system in brain ischemia: friend or foe?
    Caldeira MV; Salazar IL; Curcio M; Canzoniero LM; Duarte CB
    Prog Neurobiol; 2014 Jan; 112():50-69. PubMed ID: 24157661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubiquitin proteasome system as a pharmacological target in neurodegeneration.
    Hol EM; Fischer DF; Ovaa H; Scheper W
    Expert Rev Neurother; 2006 Sep; 6(9):1337-47. PubMed ID: 17009921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of ubiquitin proteasome system: risk for neurodegenerative diseases.
    Zheng C; Geetha T; Babu JR
    Neurodegener Dis; 2014; 14(4):161-75. PubMed ID: 25413678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of miR-181b in mouse brain following ischemic stroke induces neuroprotection against ischemic injury through targeting heat shock protein A5 and ubiquitin carboxyl-terminal hydrolase isozyme L1.
    Peng Z; Li J; Li Y; Yang X; Feng S; Han S; Li J
    J Neurosci Res; 2013 Oct; 91(10):1349-62. PubMed ID: 23900885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo transduction of neurons with TAT-UCH-L1 protects brain against controlled cortical impact injury.
    Liu H; Rose ME; Ma X; Culver S; Dixon CE; Graham SH
    PLoS One; 2017; 12(5):e0178049. PubMed ID: 28542502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the Ubiquitin C-Terminal Hydrolase L1-Modulated Ubiquitin Proteasome System in Auditory Cortex Senescence.
    Zhang Y; Huang X; Zhao XY; Hu YJ; Sun HY; Kong WJ
    ORL J Otorhinolaryngol Relat Spec; 2017; 79(3):153-163. PubMed ID: 28407635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.